Statistics for Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer
Total visits
| views | |
|---|---|
| Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer | 21 |
Total visits per month
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 1 |
| November 2025 | 0 |
| December 2025 | 0 |
File Visits
| views | |
|---|---|
| Oncogene.pdf | 57 |
| Dina_Coelho.pdf | 1 |
Top country views
| views | |
|---|---|
| Portugal | 11 |
| United States | 4 |
| China | 3 |
| Russia | 1 |
| Turkey | 1 |
| South Africa | 1 |
Top city views
| views | |
|---|---|
| Driefontein | 1 |